Image pharmaphorum Editor Webinars Sponsored Primary care sites: A new avenue for clinical research The primary care setting offers huge potential for commercial research. Others Digital transformation in pharma TEST Using AI to make a big impact for emerging and mid-sized biopharma companies Views & Analysis Haven: The strategy that didn't fix healthcare John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. Views & Analysis 4 principles for the future of pharma marketing COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? Load more results
Webinars Sponsored Primary care sites: A new avenue for clinical research The primary care setting offers huge potential for commercial research.
Others Digital transformation in pharma TEST Using AI to make a big impact for emerging and mid-sized biopharma companies
Views & Analysis Haven: The strategy that didn't fix healthcare John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare.
Views & Analysis 4 principles for the future of pharma marketing COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing?
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.